Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury
Year: 2018
Type: article
Source: Neurobiology of Disease
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: glucagon-like peptide-1 analogues, mild traumatic brain injury, pharmacokinetics, neuroprotection, cognitive impairment, neuronal cell death, neuroinflammation, brain drug delivery, weight-drop injury model, Alzheimer's disease, Parkinson's disease, multiple system atrophy, multiple sclerosis
Open Access status: green
OpenAlex ID: W2900518009
